Your Notifications
All done, no notifications

What is Guillain-Barré Syndrome (GBS)?

Guillain-Barré Syndrome (GBS) is a rare neurological disorder in which the immune system mistakenly attacks the peripheral nerves. This can interfere with nerve signals that control muscle movement and sensation, causing tingling, numbness and progressive muscle weakness. Weakness often begins in the legs and may spread to the arms and upper body. In severe cases, GBS can cause paralysis, difficulty swallowing or breathing, and abnormalities in heart rate or blood pressure.

What is the Importance of Timely Treatment?

GBS can progress rapidly over hours or days and may affect the muscles required for breathing and swallowing. Early hospital assessment allows doctors to monitor respiratory function, heart rate, blood pressure and neurological changes and to start immunotherapy when indicated. Prompt treatment with intravenous immunoglobulin (IVIG) or plasma exchange can shorten the acute illness, while supportive and intensive care can help manage potentially serious complications.

What are the Common Symptoms of Guillain-Barré Syndrome (GBS)?

  • Tingling or pins-and-needles sensations, particularly in the feet or hands
  • Weakness that usually begins in both legs
  • Difficulty walking, climbing stairs or standing
  • Weakness spreading to the arms and upper body
  • Loss or reduction of deep-tendon reflexes
  • Muscle or nerve pain
  • Difficulty with facial movements or facial weakness
  • Difficulty speaking, chewing or swallowing
  • Problems with coordination or balance
  • Abnormal heart rate or blood-pressure fluctuations
  • Difficulty breathing in severe cases
  • Paralysis in severe or rapidly progressive disease

Causes and Risk Factors of Guillain-Barré Syndrome (GBS)

Causes

  • GBS usually develops when an abnormal immune response damages peripheral nerves, often following an infection. Campylobacter jejuni, a bacterium that can cause gastrointestinal infection, is one recognised trigger.
  • Other reported triggers include respiratory or gastrointestinal infections and infections such as influenza, cytomegalovirus, Epstein-Barr virus and Zika virus.
  • In rare cases, GBS may occur after vaccination or surgery, although the absolute risk following vaccination is extremely low.

Risk Factors

  • Recent gastrointestinal or respiratory infection
  • Recent Campylobacter jejuni infection
  • Certain viral infections, including CMV, EBV, influenza or Zika virus
  • Older age
  • Rarely, recent surgery or vaccination
  • Previous GBS, although recurrence is uncommon

Latest Research and Technologies in the Treatment of Guillain-Barré Syndrome (GBS) in Singapore

  • Current GBS research focuses on understanding the immune mechanisms behind nerve injury and developing treatments that improve recovery and reduce long-term disability. IVIG and plasma exchange remain the established immunotherapies for appropriate patients, while research continues into targeted immune therapies and treatments directed at complement and other components of the autoimmune response. Advanced neurological monitoring, electrophysiological testing, respiratory monitoring and multidisciplinary rehabilitation are increasingly important for managing severe disease and supporting functional recovery.

Treatment options for Guillain-Barré Syndrome (GBS)

Intravenous Immunoglobulin (IVIG): IVIG is an established immunotherapy for GBS and works by modifying the abnormal immune response responsible for nerve injury. It is generally administered early in the disease course in patients who meet treatment criteria.

Plasma Exchange : Therapeutic plasma exchange removes circulating antibodies and other immune factors from the blood and replaces the plasma component. It can accelerate neurological recovery and is an established treatment for appropriate patients with GBS.

Cost Start From 1500Explore Options

  • Clinical assessment:
    • Neurological Evaluation: A detailed neurological examination assesses the pattern and progression of weakness, sensory symptoms, coordination, gait and deep-tendon reflexes. Doctors also evaluate facial, swallowing and respiratory muscle function and look for features that may suggest an alternative neurological diagnosis.
    • Respiratory and Autonomic Assessment: Assess heart rate, blood pressure, oxygenation, and other autonomic functions to identify complications that may require higher-level monitoring or intensive care.
    • Electrophysiological Assessment: Nerve conduction studies and electromyography (EMG) can provide supportive evidence of peripheral nerve dysfunction and help characterise the pattern of nerve involvement.
    • Cerebrospinal Fluid Assessment: An elevated protein level with a relatively low white-cell count can support the diagnosis, although CSF findings may be normal early in the illness and testing should not unnecessarily delay treatment.
    • Laboratory and Differential Diagnosis: Blood tests and other investigations may be performed when clinically indicated to identify infections, metabolic abnormalities or alternative causes of rapidly progressive weakness.
  • Imaging Tests:
    • MRI of the Spine: May be used when the diagnosis is uncertain or to exclude spinal cord compression, inflammation or other causes of acute weakness.
    • MRI of the Brain: Consider when neurological symptoms suggest an alternative central nervous system disorder.
    • Chest Imaging: Chest X-ray or other imaging may be used when respiratory complications, aspiration or infection are suspected.
    • Ultrasound and Other Tests: Additional investigations may assess complications such as blood clots or other conditions, depending on the patient's clinical status.

MediRehab (a chain of Rehab centres, part of MediGence) provides comprehensive tele - rehabilitation services designed to support Guillain-Barré Syndrome (GBS) patients in Singapore. These services include:

  • Early Positioning and Mobility
    Physiotherapists help maintain safe positioning, joint mobility and circulation during the acute phase while avoiding excessive fatigue or muscle injury.
  • Strength and Motor Rehabilitation
    As nerve function begins to recover, progressive exercises can help rebuild muscle strength, balance, coordination and functional movement.
  • Walking and Functional Training
    Patients with lower-limb weakness may receive gait training, transfer practice and assistive-device support to gradually regain mobility and independence.
  • Speech and Swallowing Rehabilitation
    Speech and language therapists may help patients with facial weakness, speech difficulties or swallowing problems and support safe nutrition when bulbar muscles are affected.
  • Occupational and Psychological Support
    Occupational therapy can help patients regain independence in daily activities, while psychological support may help with anxiety, frustration, fatigue and adjustment during a prolonged recovery.
  • Medicines used in GBS primarily aim to modify the immune response and manage symptoms or complications. Intravenous immunoglobulin (IVIG) and therapeutic plasma exchange are the principal immunotherapies used for appropriate patients and have similar overall effectiveness in severe GBS. Pain medicines may be needed for neuropathic or musculoskeletal pain, and medicines may also be used to manage blood-pressure fluctuations, abnormal heart rhythms, constipation, or other complications.

Instantly Connect with our Specialists

Doctor 1
Doctor 2
Doctor 3
Doctor 4
Doctor 5
Doctor 6
Doctor 7
Doctor 8

Hospitals for Guillain-Barré Syndrome (GBS) in Singapore

Farrer Park Hospital: Top Doctors, and Reviews
Farrer Park Hospital

Singapore, Singapore

Apart from in-detail treatment procedures available, Farrer Park Hospital located in Connexion, Singapore has a wide variety of facilities available for International Patients. Some of the facilities which are provided by them are Accommodation, Airport Transfer, Choice of Meals, Interpreter, SIM, TV inside room. Also listed below are some of the most prominent infrastructural details:

  • A medical centre is linked to the Farrer Park Hospital Complex, Connexion, Singapore
  • The focus of the hospital is to bring together two essential elements: those of healthcare combined with hospitality.
  • There is a building with 20 different stories which comprises Owen Link, hotel and spa.
  • Personal attention and patient care focus is maintained with a system in place of listening, analysing, evaluating and then implementing a treatment plan.
  • 121 bed capacity
  • Technology and innovations help provide the best of medical and surgical treatment options.
  • Professionally implemented international patient care systems
  • Suites: Cardiovascular, day surgery, endoscopy, major surgery, nuclear medicine, radiation oncology, and inpatient suite
  • Diagnostic imaging and intensive care unit
  • 24 hour emergency clinic and pharmacy
  • Facilities such as dialysis, nutrition services, rehab centre, and teaching clinic
Message Us

279

PROCEDURE

14

SPECIALITIES

7+

FACILITIES & AMENITIES

Our Services to better your experience

Opinion & Option

We submit the most accurate opinion and options from one or more countries for your review

Consult Privately

Consult with a certified specialist privately on our telemedicine platform even before you decide to travel

Logistics

We handle flights, visas, transfers, and accommodation—so you can focus on your health.

Recovery

Our In-house rehabilitation service packages to better your recovery and treatment outcome

Why Choose Singapore for Guillain-Barré Syndrome (GBS) Treatment?

  • Multidisciplinary Neurological Care: Patients can access neurologists, neurocritical-care specialists, physiotherapists, respiratory specialists, and rehabilitation teams as needed.
  • Advanced Neurological Diagnostics: Specialised centres may provide nerve conduction studies, EMG, lumbar puncture, advanced imaging and continuous neurological monitoring.
  • Immunotherapy Facilities: Major neurological centres can provide IVIG and therapeutic plasma exchange for appropriately selected patients.
  • Critical and Respiratory Care: Severe GBS may require intensive care, ventilatory support, cardiac monitoring and management of autonomic complications.
  • Comprehensive Rehabilitation and International Patient Support: Physiotherapy, occupational therapy, speech and swallowing rehabilitation, nutritional support and international-patient coordination can be incorporated into the treatment pathway.

Frequently Asked Questions

Recovery varies considerably depending on the severity of nerve damage, how rapidly symptoms progressed and the presence of complications. Many people begin to recover within a few weeks after the acute phase, but regaining strength and independence can take several months. Some patients may require rehabilitation for a year or longer, and a proportion may have persistent weakness or other nerve-related symptoms.

Some people with mild GBS can continue walking, while others temporarily lose the ability to walk because of progressive muscle weakness. Walking ability can change rapidly during the acute phase. Rehabilitation and gradual strengthening can help patients regain mobility as nerve function recovers.

Major Singapore neurological centres may provide nerve conduction studies, EMG, lumbar puncture, advanced neuroimaging, IVIG, therapeutic plasma exchange, respiratory monitoring and intensive-care support for severe GBS.

Many major Singapore hospitals have international-patient departments that can assist with medical records, specialist consultations, treatment coordination, travel arrangements, accommodation and follow-up care.

Consider a centre with experienced neurologists and access to IVIG, plasma exchange, electrophysiological testing, respiratory monitoring and intensive neurological care. If significant weakness is present, access to neurocritical care and a multidisciplinary rehabilitation programme is also important.

There is no single success rate for GBS treatment because recovery varies with disease severity, subtype, speed of progression, respiratory involvement, complications and treatment timing. Most people recover substantially or fully, although some may experience persistent weakness, fatigue, pain or other neurological problems.

Neurologists and neurocritical-care specialists at specialised Singapore centres manage GBS, including rapidly progressive weakness, respiratory complications, autonomic dysfunction and treatment with IVIG or plasma exchange. Patients with severe disease may benefit from centres with intensive-care and comprehensive rehabilitation facilities.

Risks depend on the treatment and the patient's condition. IVIG can cause treatment-related adverse effects, while plasma exchange may cause complications related to vascular access, fluid balance, blood pressure or infection. Intensive-care treatments and mechanical ventilation can also cause complications. The risks of untreated or rapidly progressive GBS can be serious because the condition may affect breathing, swallowing, heart rate and blood pressure.

Recurrence is uncommon, affecting a small percentage of patients. Symptoms that return or keep worsening beyond about 8 weeks may point to a related long-term condition called CIDP, which needs a different treatment plan, so see your neurologist if this happens.

Yes. Weakness, fatigue, pain, difficulty walking and prolonged rehabilitation can affect work, education, self-care, mobility and emotional well-being. Early supportive care and a structured rehabilitation programme can help patients regain independence and adapt to any persistent symptoms.

Yes. Rapidly progressive or untreated GBS can cause severe paralysis, respiratory failure, swallowing difficulties, autonomic instability and other potentially life-threatening complications. Some patients may also develop persistent weakness, sensory symptoms, fatigue or pain after the acute illness.

There is no guaranteed way to prevent GBS because it is an abnormal immune response that can occur after different infections and, rarely, other triggers. Reducing infection risk through proper food and water hygiene, hand hygiene, and recommended preventive measures may reduce exposure to some recognised triggers. Vaccination remains an important preventive health measure, and the risk of GBS following vaccination is very low compared with the risk associated with some infections.

GBS can affect people of any age. It is reported more frequently in adults and males, and the risk increases with age. A recent gastrointestinal or respiratory infection is a well-recognised association. However, GBS can occur without an identifiable trigger.

Author

Dr. Vijita Jayan
Dr. Vijita Jayan

BPT, MPT (Neuro)

18 Years of Experience

With over 18 years of distinguished clinical experience, Dr. Vijita Jayan is a highly accomplished Clinical Director and Rehabilitation Specialist, renowned for her expertise in neuro-rehabilitation, functional recovery, and mobility-dependent case management. Her extensive practical knowledge enables her to design and implement individualized, evidence-based rehabilitation protocols that consistently yield measurable patient outcomes. A prolific researcher and academic writer, she has authored numerous peer-reviewed articles and research papers, significantly advancing the field of rehabilitative medicine. The recipient of multiple prestigious accolades, Dr. Jayan is widely regarded as one of the foremost authorities in Physical Medicine and Rehabilitation, continually shaping neuro-rehabilitative care through research, innovation, and clinical excellence. View More

Reviewer

Dr. Akash Khandelwal
Dr. Akash Khandelwal

Hematologist

9 Years of Experience

Dr. Akash Khandelwal is a distinguished Hematologist, Hemato-oncologist, and Bone Marrow Transplant (BMT) Physician with extensive training from the prestigious AIIMS New Delhi. His expertise encompasses a wide range of specialized techniques in bone marrow transplantation, including autologous and allogeneic transplants such as matched sibling donors, matched unrelated donors (MUD), and haploidentical donor transplants. Dr. Khandelwal has personally supervised and conducted over 100 bone marrow transplants. View More

Last Reviewed - January 2026